Fundraising FoxTr1X Bio
2 known investors
Find your way into Tr1X Bio
Sign up to find every way you can get introduced to Tr1X Bio
- Your email: who you already know at Tr1X Bio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Tr1X Bio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Tr1X is a biopharmaceutical company developing cell and gene therapies to cure autoimmune and inflammatory diseases with high unmet medical need. The company translates scientific discoveries in immune regulation and regenerative medicine into novel patient therapies.
Founders & leadership
D
DavidCo-Founder
MG
Maria Grazia RoncaroloCo-Founder, President and Head of R&D
Investors · 2
Neva Sgr.listed by Neva Sgr.Turin
How we know: Neva Sgr.'s portfolio page · press coverage · the VCSheet dataset · Not right? Tell us
The Column Grouplisted by The Column GroupSan Francisco · $30M
How we know: The Column Group's portfolio page · press coverage · the VCSheet dataset · Not right? Tell us
In the news
Frequently asked questions
- What does Tr1X Bio do?
- Tr1X is a biopharmaceutical company developing cell and gene therapies to cure autoimmune and inflammatory diseases with high unmet medical need. The company translates scientific discoveries in immune regulation and regenerative medicine into novel patient therapies.
- Who founded Tr1X Bio?
- Tr1X Bio was founded by David, Maria Grazia Roncarolo.
- Who are Tr1X Bio's investors?
- Tr1X Bio's investors include Neva Sgr., The Column Group.